Eventide Healthcare Life Fund Investor Sentiment

ETCHX Fund  USD 28.82  0.26  0.89%   
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
EVENTIDE HEALTHCARE LIFE SCIENCES FUND CELEBRATES ... - Valdosta Daily Times
Google News at Macroaxis
a day ago at thelincolnianonline.com         
Collegium Pharmaceutical, Inc. EVP Shirley R. Kuhlmann Sells 26,067 Shares of Stock
news
3 days ago at www.macroaxis.com         
Disposition of 20000 shares by Shirley Kuhlmann of Collegium Pharmaceutical at 28.0264 subject to Ru...
Macroaxis News
few days ago at www.macroaxis.com         
Disposition of 9826 shares by Shirley Kuhlmann of Collegium Pharmaceutical at 30.52 subject to Rule ...
Macroaxis News
six days ago at thelincolnianonline.com         
Collegium Pharmaceutical Shares Gap Up After Better-Than-Expected Earnings
news
over a week ago at finance.yahoo.com         
Collegium Pharmaceutical Q4 Earnings Taking a Look at Key Metrics Versus Estimates
Yahoo News
over a week ago at finance.yahoo.com         
Collegium Pharmaceutical Inc Q4 2024 Earnings Call Highlights Record Revenue Growth and ...
Yahoo News
over a week ago at simplywall.st         
Is Collegium Pharmaceutical, Inc.s 38 percent ROE Better Than Average?
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Collegium Pharmaceutical Q4 Earnings Snapshot
Yahoo News
over a week ago at finance.yahoo.com         
Collegium Pharmaceutical Q4 Earnings and Revenues Beat Estimates
Yahoo News
over a week ago at gurufocus.com         
What To Expect From Collegium Pharmaceutical Inc Q4 2024 Earnings
Gurufocus Stories at Macroaxis
over six months ago at seekingalpha.com         
Tectonic, AVROBIO complete merger, announce 130.7M private placement
seekingalpha News
over six months ago at news.google.com         
Gabelli Funds LLC Invests 467000 in AVROBIO, Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
AVROBIO, Inc. Short Interest Up 11.3 percent in May - MarketBeat
Google News at Macroaxis
over six months ago at investing.com         
Avrobio executive buys shares worth over 970k
Investing News at Macroaxis
over six months ago at investorplace.com         
Discretionary transaction by Leonard Braden Michael of tradable shares of AVROBIO subject to Rule 16...
sbwire news
over six months ago at news.google.com         
AVROBIO Options Chain Prices 2024 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
AVROBIO Posts Quarterly Earnings Results - MarketBeat
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
AVROBIO, Inc. Short Interest Update
news
over a year ago at benzinga.com         
SHAREHOLDER UPDATE Halper Sadeh LLC Investigates AXNX, KAMN, JNPR, AVRO
benzinga news
over a year ago at news.google.com         
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates...
Google News at Macroaxis
a day ago at finance.yahoo.com         
Disposition of 2625 shares by Frank Mottola of Supernus Pharmaceuticals subject to Rule 16b-3
Yahoo News
few days ago at gurufocus.com         
Supernus Pharmaceuticals Inc Announces Participation in March Investor Conferences
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Is Supernus Pharmaceuticals, Inc. the Best Small Cap Pharma Stocks to Buy Now?
Yahoo News
over a week ago at finance.yahoo.com         
Earnings To Watch Amneal Reports Q4 Results Tomorrow
Yahoo News
over a week ago at gurufocus.com         
Supernus Pharmaceuticals Inc Announces Participation in TD Cowen Health Care Conference
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Supernus Pharmaceuticals Inc Q4 2024 Earnings Call Highlights Strong Revenue Growth ...
Yahoo News
over a week ago at insidermonkey.com         
Supernus Pharmaceuticals, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over a week ago at finance.yahoo.com         
Supernus Q4 Earnings How Key Metrics Compare to Wall Street Estimates
Yahoo News
over a week ago at gurufocus.com         
Supernus Announces Fourth Quarter and Full Year 2024 Financial Results
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Supernus Pharmaceuticals Delivers Strong Q4 Numbers
Yahoo News
a day ago at gurufocus.com         
Insider Sell Phillip Febbo Sells Shares of Veracyte Inc
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Veracyte Full Year 2024 Earnings EPS Misses Expectations
Yahoo News
few days ago at finance.yahoo.com         
Veracytes Performance Is Even Better Than Its Earnings Suggest
Yahoo News
over a week ago at thelincolnianonline.com         
Veracyte Price Target Raised to 49.00
news
over a week ago at thelincolnianonline.com         
Veracyte Announces Quarterly Earnings Results
news
over a week ago at benzinga.com         
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says Walking Away Is A Long-T...
benzinga news
over a week ago at gurufocus.com         
Q4 2024 Veracyte Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over a week ago at seekingalpha.com         
Veracyte Non-GAAP EPS of 0.36 beats by 0.10, revenue of 118.63M beats by 1.94M
seekingalpha News
over a week ago at zacks.com         
Veracyte Q4 Earnings and Revenues Beat Estimates
zacks News
over a week ago at finance.yahoo.com         
Disposition of 5309 shares by Eastham Karin of Veracyte at 40.1224 subject to Rule 16b-3
Yahoo News
a day ago at thelincolnianonline.com         
E Fund Management Co. Ltd. Sells 342 Shares of Alnylam Pharmaceuticals, Inc.
news
3 days ago at finance.yahoo.com         
Grove AI Awarded the SCOPE Participant Engagement Award for Its AI-Powered Digital Staff and Platfor...
Yahoo News
few days ago at finance.yahoo.com         
Disposition of 120 shares by Garg Pushkal of Alnylam Pharmaceuticals at 242.7 subject to Rule 16b-3
Yahoo News
few days ago at thelincolnianonline.com         
Alnylam Pharmaceuticals, Inc. Stock Holdings Cut by Asahi Life Asset Management CO. LTD.
news
over a week ago at thelincolnianonline.com         
Alnylam Pharmaceuticals Buy Rating Reaffirmed at Needham Company LLC
news
over a week ago at statnews.com         
Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide
news
over a week ago at finance.yahoo.com         
Global Oligonucleotide Synthesis Market to Cross USD 7 Billion by 2032 DelveInsight
Yahoo News
over a week ago at gurufocus.com         
Alnylam Pharmaceuticals Inc Showcases RD Progress and Platform Innovation at RD Day
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
Exploring None And 2 High Growth Tech Stocks For Your Portfolio
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Alnylam Pharmaceuticals, Inc. CMO Sells 8,320.37 in Stock
news
3 days ago at news.google.com         
Bluebird bios chief commercial officer sells 1,959 in stock - Investing.com
Google News at Macroaxis
few days ago at prnewswire.com         
Disposition of 921 shares by Andrew Obenshain of Bluebird Bio at 3.9194 subject to Rule 16b-3
prnewswire News
over a week ago at prnewswire.com         
MONSTER ENERGY LAUNCHES NEW ZERO SUGAR ULTRA BLUE HAWAIIAN
prnewswire News
over two weeks ago at talkmarkets.com         
Stocks Firmly Lower As Consumer Sentiment Weakens
news
over two weeks ago at businesswire.com         
Shareholder Alert Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for it...
businesswire News
over two weeks ago at businesswire.com         
BLUE Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of bluebird bio, Inc. Is Fair to...
businesswire News
over two weeks ago at news.google.com         
bluebird bio Share Price Passes Below 200 Day Moving Average - Heres What Happened - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
bluebird bio, Inc. Receives Average Rating of Hold from Brokerages - MarketBeat
Google News at Macroaxis
over a month ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ELECTS COREY THOMAS AS NEW BOARD CHAIR AND NAMES PETER LONG ...
prnewswire News
over a month ago at finance.yahoo.com         
Blue Buffalo Supports Pet Parents Impacted by the California Wildfires with Food and Resources to He...
Yahoo News
2 days ago at finance.yahoo.com         
CytomX Therapeutics Tops Q4 Earnings and Revenue Estimates
Yahoo News
few days ago at gurufocus.com         
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Voyager Reports Positive Topline Data for Single Ascending Dose Trial of Anti-Tau ...
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
VOYAGER ALERT Bragar Eagel Squire, P.C. is Investigating Voyager Therapeutics, Inc. ...
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Jorgensen Nathan D. of 103000 shares of Voyager Therapeutics at 4.22 subject to Rule ...
Macroaxis News
over two weeks ago at gurufocus.com         
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. ...
Gurufocus Stories at Macroaxis
over three weeks ago at simplywall.st         
Insiders Sold Voyager Therapeutics Prematurely At US7.47 With Stock Trading Higher
Simply Wall St News at Macroaxis
over three weeks ago at gurufocus.com         
Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
What Makes Voyager Therapeutics a New Buy Stock - Yahoo Finance
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 5000 shares by Todd Carter of Voyager Therapeutics at 2.85 subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Stonepine Capital Management, LLC Acquires Significant Stake in Edesa Biotech Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Galapagos NV Earnings Call Highlights Strategic Shifts and Financial Resilience
Gurufocus Stories at Macroaxis
over three weeks ago at seekingalpha.com         
Galapagos projects 2026 pivotal trials for GLPG5101 following FDA clearance
seekingalpha News
over a month ago at finance.yahoo.com         
Galapagos Loses -21.19 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
Yahoo News
over a month ago at news.google.com         
Galapagos downgraded by Barclays, PT cut to 22 - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
Belgium stocks lower at close of trade BEL 20 down 1.58 percent - Investing.com
Google News at Macroaxis
over three months ago at gurufocus.com         
Galapagos NV Stock Surges Amid Strong Industry Performance
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Stonepine Capital Management, LLC Increases Stake in Verastem Inc
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Prosight Management, LP Expands Stake in ADC Therapeutics SA
Gurufocus Stories at Macroaxis
over three months ago at insidermonkey.com         
Galapagos NV Q3 2024 Earnings Call Transcript
insidermonkey News
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a day ago at benzinga.com         
AbbVie Options Trading A Deep Dive into Market Sentiment
benzinga news
3 days ago at simplywall.st         
AbbVie Expands SKYRIZI Availability In Canada For Ulcerative Colitis Treatment
Simply Wall St News at Macroaxis
few days ago at thelincolnianonline.com         
Commerzbank Aktiengesellschaft FI Acquires 19,291 Shares of AbbVie Inc.
news
few days ago at zacks.com         
Disposition of 2918 shares by Perry Siatis of AbbVie at 144.54 subject to Rule 16b-3
zacks News
few days ago at zacks.com         
AbbVie Rises As Market Takes a Dip Key Facts
zacks News
few days ago at thelincolnianonline.com         
AbbVie Shares Up 0.3 percent Heres What Happened
news
few days ago at finance.yahoo.com         
Is Ironwood Pharmaceuticals, Inc. the Best Small Cap Pharma Stocks to Buy Now?
Yahoo News
six days ago at thelincolnianonline.com         
Roanoke Asset Management Corp NY Decreases Stake in AbbVie Inc.
news
six days ago at insidermonkey.com         
AbbVie Inc. Among the Best Psychedelic Stocks to Buy in 2025
insidermonkey News
over a year ago at hawaiinewsnow.com         
Purchase by Sumitomo Chemical Co Ltd of 51599200 shares of Myovant Sciences
news
a day ago at zacks.com         
SLDB Stock Rallies 60 percent in a Month Heres What You Should Know
zacks News
few days ago at finance.yahoo.com         
Disposition of 1704 shares by Rodino-klapac Louise of Sarepta Therapeutics at 101.34 subject to Rule...
Yahoo News
six days ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
over a week ago at finance.yahoo.com         
Rare disease treatments skipping UK patients largely due to costs, survey shows
Yahoo News
over a week ago at fool.com         
Sarepta Therapeutics Q4 2024 Earnings Call Transcript
fool News
over a week ago at insidermonkey.com         
Sarepta Therapeutics, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over a week ago at zacks.com         
Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene Therapy Sales
zacks News
over a week ago at seekingalpha.com         
Sarepta Therapeutics Non-GAAP EPS of 1.90 misses by 0.16, revenue of 658.4M beats by 27.37M
seekingalpha News
over a week ago at finance.yahoo.com         
Sarepta Therapeuticss Q4 Beats On Revenue
Yahoo News
over a week ago at finance.yahoo.com         
Sarepta Therapeutics Lags Q4 Earnings Estimates
Yahoo News
over a year ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over a year ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over a year ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over a year ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over a year ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
a minute ago at gurufocus.com         
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
Gurufocus Stories at Macroaxis
3 days ago at simplywall.st         
908 Devices Inc.s 55 percent Jump Shows Its Popularity With Investors
Simply Wall St News at Macroaxis
few days ago at gurufocus.com         
908 Devices Inc Q4 2024 Earnings EPS Misses, Revenue Beats Estimates with 18.8 Million
Gurufocus Stories at Macroaxis
few days ago at businesswire.com         
Acquisition by Turner Michael S. of 57111 shares of 908 Devices at 1.98 subject to Rule 16b-3
businesswire News
over a week ago at prnewswire.com         
ARKEMA OBTAINS MASS BALANCE ISCC PLUS CERTIFICATION FOR ADVANCED LIQUID RESINS PRODUCTION FACILITY I...
prnewswire News
over a week ago at finance.yahoo.com         
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
Yahoo News
over two weeks ago at gurufocus.com         
Catherine Woods Strategic Reduction in 908 Devices Inc An In-Depth Analysis
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
908 Devices Inc. CFO Joseph H. Iv Griffith Sells 10,236 Shares
news
over a month ago at www.macroaxis.com         
Disposition of 5027 shares by Christopher Brown of 908 Devices subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
908 Devices Earns Sell Rating from Weiss Ratings - MarketBeat
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
3 days ago at simplywall.st         
Neurocrine Biosciences, Inc.s Stock Retreats 25 percent But Earnings Havent Escaped The Attention Of...
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
Dopamine Receptor Antagonists Clinical Trial Pipeline Analysis 10 Key Companies Shaping the Future o...
Yahoo News
over a week ago at finance.yahoo.com         
Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus
Yahoo News
over a week ago at finance.yahoo.com         
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
Yahoo News
over a week ago at gurufocus.com         
Neurocrine Biosciences Inc Stock Price Up 3.94 percent on Feb 23
Gurufocus Stories at Macroaxis
over two weeks ago at insidermonkey.com         
Is Neurocrine Biosciences One of the Best Fast Growth Stock to Buy Right Now?
insidermonkey News
over two weeks ago at finance.yahoo.com         
Neurocrine Among Top Insider Stock Buys And Sells In January
Yahoo News
over two weeks ago at thelincolnianonline.com         
Neurocrine Biosciences, Inc. Shares Bought by Van ECK Associates Corp
news
over two weeks ago at finance.yahoo.com         
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 20...
Yahoo News
a day ago at news.google.com         
Nurix Therapeutics Shares Down 6 percent on Insider Selling - MarketBeat
Google News at Macroaxis
few days ago at gurufocus.com         
Nurix Therapeutics Inc Announces Participation in Key March Conferences
Gurufocus Stories at Macroaxis
over a week ago at news.google.com         
ARK Investment Management LLC Sells 686,072 Shares of Nurix Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at gurufocus.com         
Nurix Therapeutics Inc Announces Inducement Awards to New Employees
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
over three weeks ago at kalkinemedia.com         
Acquisition by Van Houte Hans of 34300 shares of Nurix Therapeutics subject to Rule 16b-3
news
over a month ago at gurufocus.com         
Nurix Therapeutics Inc to Participate in Oppenheimer Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Needham Company LLC Cuts Nurix Therapeutics Price Target to 28.00
news
over a month ago at simplywall.st         
Companies Like Nurix Therapeutics Are In A Position To Invest In Growth
Simply Wall St News at Macroaxis
over a month ago at news.google.com         
Nurix Therapeutics, Inc. Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Global markets live Adobe, Eli Lilly, Nasdaq, Intel, UBS... - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Boxer Capital LLC Boosts Stock Position in Prometheus Biosciences, Inc.
news
over a year ago at www.macroaxis.com         
Exercise or conversion by Mark McKenna of 122528 shares of Prometheus Biosciences subject to Rule 16...
Macroaxis News
over a year ago at news.google.com         
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, L...
Google News at Macroaxis
over a year ago at simplywall.st         
We Think Prometheus Biosciences Can Afford To Drive Business Growth
Simply Wall St News at Macroaxis
over a year ago at zacks.com         
Prometheus Biosciences, Inc. is a Great Momentum Stock Should You Buy?
zacks News
over a year ago at zacks.com         
Prometheus Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates
zacks News
over a year ago at news.google.com         
Ieq Capital LLC Sells off 35.3 percent of Holding in Prometheus ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors - Marketscre...
Google News at Macroaxis
over a year ago at fool.com         
Why Madrigal Pharmaceuticals Stock Gained 20 percent This Week
fool News
over six months ago at www.macroaxis.com         
Disposition of 8500 shares by Jonas Jeffrey M of Karuna Therapeutics at 128.01 subject to Rule 16b-3
Macroaxis News
over six months ago at bizjournals.com         
PureTechs newest biotech spinout represents a shift from the past
bizjournals News
over six months ago at news.google.com         
Disposition of 17350 shares by Stephen Brannan of Karuna Therapeutics at 187.26 subject to Rule 16b-...
Google News at Macroaxis
over six months ago at simplywall.st         
When Will Karuna Therapeutics, Inc. Turn A Profit?
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
Karuna Therapeutics, Inc. Receives Consensus Recommendation of Hold from Analysts - Defense World
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics Short Position
Yahoo News
over a year ago at www.macroaxis.com         
Acquisition by Steven Paul of 47378 shares of Karuna Therapeutics at 315.18 subject to Rule 16b-3
Macroaxis News
over a year ago at seekingalpha.com         
Karuna Therapeutics stock drops on no apparent news amid deal with Bristol-Myers Squibb
seekingalpha News
over a year ago at thelincolnianonline.com         
Algert Global LLC Has 3.12 Million Stock Holdings in Karuna Therapeutics, Inc.
news
over a year ago at zacks.com         
Acquisition by Steven Paul of 27510 shares of Karuna Therapeutics at 7.27 subject to Rule 16b-3
zacks News
3 days ago at www.macroaxis.com         
Disposition of 8750 shares by Edward Albini of Sutro Biopharma subject to Rule 16b-3
Macroaxis News
six days ago at www.macroaxis.com         
Disposition of 11250 shares by Borgman Anne Elizabeth of Sutro Biopharma subject to Rule 16b-3
Macroaxis News
over three weeks ago at simplywall.st         
Shareholders in Sutro Biopharma have lost 86, as stock drops 18 percent this past week
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Were Not Very Worried About Sutro Biopharmas Cash Burn Rate
Yahoo News
over a month ago at simplywall.st         
Great week for Sutro Biopharma, Inc. institutional investors after losing 42 percent over the previo...
Simply Wall St News at Macroaxis
over two months ago at www.macroaxis.com         
Acquisition by Venkatesh Srinivasan of 5000 shares of Sutro Biopharma subject to Rule 16b-3
Macroaxis News
over two months ago at kalkinemedia.com         
Is Sutro Biopharma Set to Dominate Over Novavax in the Stock Arena?
news
over two months ago at gurufocus.com         
Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization ...
Gurufocus Stories at Macroaxis
over three months ago at thelincolnianonline.com         
Disposition of 8920 shares by Chung Jane of Sutro Biopharma at 2.69 subject to Rule 16b-3
news
over three months ago at news.google.com         
Brokers Set Expectations for Sutro Biopharma FY2024 Earnings - MarketBeat
Google News at Macroaxis
few days ago at thelincolnianonline.com         
Xencor Sets New 1-Year Low Heres Why
news
over a week ago at gurufocus.com         
Decoding Xencor Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Xencor Full Year 2024 Earnings Beats Expectations
Yahoo News
over a week ago at finance.yahoo.com         
Xencor Q4 Earnings Snapshot
Yahoo News
over a week ago at finance.yahoo.com         
Xencor Reports Q4 Loss, Tops Revenue Estimates
Yahoo News
over a week ago at zacks.com         
BioCryst Pharmaceuticals Reports Q4 Loss, Tops Revenue Estimates
zacks News
over three weeks ago at zacks.com         
Enanta Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
zacks News
over three weeks ago at zacks.com         
Xencor Loses -25.22 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
zacks News
over a month ago at finance.yahoo.com         
Xencor NASDAQXNCR investor five-year losses grow to 50 percent as the stock sheds US96m this past we...
Yahoo News
over a month ago at news.google.com         
Investment Analysis - Stock Traders Daily
Google News at Macroaxis
2 days ago at www.macroaxis.com         
Disposition of 31370 shares by Robert Alexander of Allakos at 0.26 subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reve...
Yahoo News
over a month ago at thelincolnianonline.com         
Piper Sandler Downgrades Allakos to Hold
news
over a month ago at gurufocus.com         
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic ...
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
Discover US Penny Stocks To Watch In January 2025 - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Point72 Asset Management L.P. Purchases New Position in Allakos Inc. - MarketBeat
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 32466 shares by Robert Alexander of Allakos at 1.1 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Allakos Inc. finalizes early lease termination, incurring 2.5 million in costs - Investing.com
Google News at Macroaxis
over three months ago at zacks.com         
All You Need to Know About Allakos Rating Upgrade to Buy
zacks News
over three months ago at news.google.com         
10 Health Care Stocks Whale Activity In Todays Session - Benzinga
Google News at Macroaxis
a day ago at gurufocus.com         
argenx SE Announces Promising Data for VYVGART at AAN Annual Meeting
Gurufocus Stories at Macroaxis
few days ago at kalkinemedia.com         
Is argenx SE Expanding Its Role in the Biotechnology Sector?
news
six days ago at thelincolnianonline.com         
Dynasty Wealth Management LLC Acquires 22 Shares of argenx SE
news
over a week ago at zacks.com         
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
zacks News
over a week ago at zacks.com         
CORTs Q4 Earnings and Revenues Fall Short of Estimates
zacks News
over a week ago at gurufocus.com         
argenx to Present at TD Cowen 45th Annual Healthcare Conference
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
SpringWorks Q4 Loss Wider Than Expected, Revenues Beat Estimates
zacks News
over two weeks ago at finance.yahoo.com         
Heres Why argenx SE Rose in Q4
Yahoo News
over two weeks ago at gurufocus.com         
RTW INVESTMENTS, LP Acquires Significant Stake in PepGen Inc
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
Insmeds NDA for Lung Disease Drug Gets FDAs Priority Review
zacks News
3 days ago at gurufocus.com         
Avoro Capital Advisors LLC Increases Stake in Aadi Bioscience Inc
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Ascendis Pharma AS Shares Sold by Handelsbanken Fonder AB
news
over a week ago at gurufocus.com         
Ascendis Pharma to Participate in theTD Cowen 45th Annual Healt
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Q1 EPS Forecast for Ascendis Pharma AS Decreased by Analyst
news
over two weeks ago at finance.yahoo.com         
High Growth Tech Stocks And 2 More High Potential Picks
Yahoo News
over two weeks ago at gurufocus.com         
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Day One Biopharmaceuticals Inc
Gurufocus Stories at Macroaxis
over two weeks ago at simplywall.st         
Ascendis Pharma Full Year 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over two weeks ago at gurufocus.com         
Ascendis Pharma AS Q4 2024 Earnings Call Highlights Strategic Growth and Market ...
Gurufocus Stories at Macroaxis
over three weeks ago at insidermonkey.com         
Ascendis Pharma AS Q4 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at seekingalpha.com         
Ascendis Pharma GAAP EPS of 0.64 beats by 1.85, revenue of 173.9M beats by 49.91M
seekingalpha News
a day ago at kalkinemedia.com         
Acquisition by Michael Heffernan of 52906 shares of Biohaven Pharmaceutical at 13.2 subject to Rule ...
news
3 days ago at thelincolnianonline.com         
Biohaven Announces Quarterly Earnings Results, Misses Estimates By 0.29 EPS
news
3 days ago at gurufocus.com         
Biohaven Ltd Reports Q4 2024 EPS of -1.85, Missing Estimates Revenue Details Not Provided
Gurufocus Stories at Macroaxis
few days ago at zacks.com         
Company News for Mar 4, 2025
zacks News
few days ago at gurufocus.com         
Biohaven Ltd Announces Promising Results for BHV-1300 in Autoimmune Disease Treatment
Gurufocus Stories at Macroaxis
few days ago at benzinga.com         
Strong Immunoglobulin Reduction Data Positions Biohavens BHV-1300 As Potential Autoimmune Therapy
benzinga news
over three weeks ago at finance.yahoo.com         
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Tr...
Yahoo News
over three weeks ago at seekingalpha.com         
Biohaven gets FDA acceptance and priority review of Troriluzoles NDA
seekingalpha News
over three weeks ago at gurufocus.com         
BHVN Surges on FDA Priority Review for Key Drug
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Biohaven Ltd. Given Consensus Recommendation of Buy by Analysts
news
a minute ago at benzinga.com         
IonQ, HE Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week Are The Others I...
benzinga news
3 days ago at www.macroaxis.com         
Disposition of 3530 shares by Carter Percy H. of Blueprint Medicines at 88.8 subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Blueprint Medicines Co. Receives 123.83 Consensus Target Price from Brokerages
news
over a week ago at gurufocus.com         
Blueprint Medicines Corp Showcases Promising Data on Mast Cell-Targeted Therapies at ...
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
Blueprint Medicines Corporation Among the Oversold Biotech Stocks to Buy Now
insidermonkey News
over two weeks ago at www.macroaxis.com         
Disposition of 2274 shares by Christina Rossi of Blueprint Medicines at 95.14 subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Blueprint Medicines Given Market Outperform Rating at JMP Securities
news
over two weeks ago at thelincolnianonline.com         
Blueprint Medicines Given Buy Rating at Needham Company LLC
news
over two weeks ago at gurufocus.com         
Q4 2024 Blueprint Medicines Corp Earnings Call Transcript
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
Blueprint Medicines Reports Q4 Loss, Misses Revenue Estimates
zacks News
few days ago at finance.yahoo.com         
Atopic Dermatitis 2025 Pipeline Insights Report Covering 100 Companies and 120 Pipeline Drugs, Inclu...
Yahoo News
few days ago at globenewswire.com         
Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Progra...
Macroaxis News: globenewswire.com
few days ago at thelincolnianonline.com         
Celldex Therapeutics Reaches New 52-Week Low Following Analyst Downgrade
news
six days ago at simplywall.st         
Celldex Therapeutics Full Year 2024 Earnings Revenues Beat Expectations, EPS In Line
Simply Wall St News at Macroaxis
six days ago at gurufocus.com         
Celldex Therapeutics Inc Reports Positive Phase 2 Results for Barzolvolimab in Chronic ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Celldex Q4 Earnings Snapshot
Yahoo News
over a week ago at gurufocus.com         
Celldex Therapeutics Q4 2024 Earnings EPS Matches Estimates at 0. ...
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Elizabeth Crowley of 85000 shares of Celldex Therapeutics at 36.43 subject to Rule 16...
Macroaxis News
over two weeks ago at thelincolnianonline.com         
TSP Capital Management Group LLC Has 5.64 Million Holdings in Celldex Therapeutics, Inc.
news
over three weeks ago at thelincolnianonline.com         
Celldex Therapeutics Reaches New 52-Week Low Heres What Happened
news
a day ago at gurufocus.com         
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
Gurufocus Stories at Macroaxis
over a week ago at globenewswire.com         
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdv...
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
Cogent Biosciences Reports Q4 2024 Net Loss of 67.9 Million, Exceeds EPS Estimate of -0.59
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Steven Cohens Recent Transaction with Cogent Biosciences Inc
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
Is Cogent Biosciences Outperforming Other Medical Stocks This Year?
zacks News
over three weeks ago at news.google.com         
One Cogent Biosciences Insider Raised Stake By 2,085 percent In Previous Year - Simply Wall St
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Cogent Biosciences Trading Down 5.3 percent Should You Sell?
news
over a month ago at news.google.com         
Inside Cogents Next Big Move Key Presentation Set for Guggenheim Conference - StockTitan
Google News at Macroaxis
over a month ago at news.google.com         
Assenagon Asset Management S.A. Sells 133,515 Shares of Cogent Biosciences, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Cole Pinnow Bought 2,085 percent More Shares In Cogent Biosciences
Yahoo News
a day ago at www.macroaxis.com         
Disposition of 22167 shares by Kevin Conroy of EXACT Sciences subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Grandfield Dodd LLC Purchases 4,962 Shares of Exact Sciences Co.
news
few days ago at finance.yahoo.com         
Disposition of 1055 shares by Sarah Condella of EXACT Sciences subject to Rule 16b-3
Yahoo News
over a week ago at thelincolnianonline.com         
Disposition of 3780 shares by Sarah Condella of EXACT Sciences subject to Rule 16b-3
news
over a week ago at www.macroaxis.com         
Acquisition by Orville Jacob A of 28779 shares of EXACT Sciences subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Disposition of 13180 shares by Kevin Conroy of EXACT Sciences subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Exact Sciences Corp Shares Gap Down to 49.26 on Feb 21
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Leerink Partnrs Boosts Earnings Estimates for Exact Sciences
news
over two weeks ago at seekingalpha.com         
Exact Sciences sees 13 percent screening growth in 2025 with new diagnostics launches
seekingalpha News
over two weeks ago at gurufocus.com         
Exact Sciences Corp Q4 2024 Earnings Call Highlights Strong Revenue Growth and ...
Gurufocus Stories at Macroaxis
a day ago at kalkinemedia.com         
Is Kura Oncology Seeing Increased Institutional Activity and Market Confidence?
news
over a week ago at finance.yahoo.com         
Kura Oncology shareholders have endured a 64 percent loss from investing in the stock a year ago
Yahoo News
over a week ago at finance.yahoo.com         
Kura Oncology Inc Q4 2024 Earnings Call Highlights Strategic Advances and Financial Growth
Yahoo News
over a week ago at thelincolnianonline.com         
Kura Oncology Issues Earnings Results, Beats Expectations By 0.43 EPS
news
over a week ago at gurufocus.com         
Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Kura Oncology, Inc. Given Average Rating of Moderate Buy by Brokerages
news
over two weeks ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires Additional Shares in Kura Oncology Inc
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Suvretta Capital Management, LLC Reduces Stake in Marinus Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over three weeks ago at thelincolnianonline.com         
Kura Oncology Trading 6.7 percent Higher Still a Buy?
news
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
2 days ago at seekingalpha.com         
Vertex Pharma stock drops on Journavx coverage
seekingalpha News
3 days ago at finance.yahoo.com         
Carrier and Google Cloud Join Forces to Strengthen Grid Resilience with AI-Powered Home Energy Manag...
Yahoo News
few days ago at businesswire.com         
Salesforce Launches AgentExchange the Trusted Marketplace for Agentforce
businesswire News
few days ago at kalkinemedia.com         
Vertex Wireless Opens Secondary Distribution Center to Meet Growing Demand for Technology Solutions ...
news
few days ago at prnewswire.com         
Google Cloud Enhances Vertex AI Search for Healthcare with Multimodal AI
prnewswire News
six days ago at gurufocus.com         
Insider Sell Atkinson Edward Morrow III Sells 2,650 Shares of Vertex Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Insider Buying Vertex Minerals Limited Insider Purchases A25,280.00 in Stock
news
over a week ago at thelincolnianonline.com         
Illumine Investment Management LLC Invests 2.33 Million in Vertex Pharmaceuticals Incorporated
news
over a week ago at simplywall.st         
Vertex Full Year 2024 Earnings EPS Misses Expectations
Simply Wall St News at Macroaxis
3 days ago at www.macroaxis.com         
Disposition of 12084 shares by Audhya Paul K. of Kalvista Pharmaceuticals subject to Rule 16b-3
Macroaxis News
few days ago at businesswire.com         
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
few days ago at businesswire.com         
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Ast...
businesswire News
over a week ago at www.macroaxis.com         
Disposition of 1918 shares by Christopher Yea of Kalvista Pharmaceuticals at 10.02 subject to Rule 1...
Macroaxis News
over two weeks ago at businesswire.com         
KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma...
businesswire News
over two weeks ago at businesswire.com         
KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma...
businesswire News
over two weeks ago at www.macroaxis.com         
Disposition of 5104 shares by Benjamin Palleiko of Kalvista Pharmaceuticals at 9.8242 subject to Rul...
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Acquisition by Venrock Healthcare Capital Partners Iii, L.p. of 61700 shares of Kalvista Pharmaceuti...
news
over three weeks ago at businesswire.com         
KalVista Pharmaceuticals Presents New Sebetralstat Data at the Western Society of Allergy, Asthma Im...
businesswire News
over three weeks ago at businesswire.com         
KalVista Pharmaceuticals Presents New Sebetralstat Data at the Western Society of Allergy, Asthma Im...
businesswire News
2 days ago at news.google.com         
Leerink Partnrs Weighs in on AnaptysBio FY2029 Earnings - MarketBeat
Google News at Macroaxis
six days ago at simplywall.st         
AnaptysBio Full Year 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
ANABs Certificate Accreditation Program Issues Transition Plan for Latest Version of ANSIASTM E2659 ...
Yahoo News
over a week ago at finance.yahoo.com         
AnaptysBio, Inc. Reports Q4 Loss, Tops Revenue Estimates
Yahoo News
over two weeks ago at www.macroaxis.com         
Acquisition by Daniel Faga of 107350 shares of AnaptysBio subject to Rule 16b-3
Macroaxis News
over three weeks ago at zacks.com         
AnaptysBio Surges 30.5 percent Is This an Indication of Further Gains?
zacks News
over three weeks ago at finance.yahoo.com         
Is AnaptysBio Stock Outpacing Its Medical Peers This Year?
Yahoo News
over three weeks ago at investors.com         
AnaptysBio Whipsaws On Promising Results In Rheumatoid Arthritis Treatment
Investors Business Daily at Macroaxis
over three weeks ago at gurufocus.com         
Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and ...
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
AnaptysBio Upgraded to Strong-Buy at Wolfe Research
news
a day ago at thelincolnianonline.com         
Acquisition by Abi-saab Walid of 66000 shares of Uniqure NV at 10.9 subject to Rule 16b-3
news
few days ago at www.macroaxis.com         
Disposition of 7076 shares by Potts Jeannette of Uniqure NV at 10.29 subject to Rule 16b-3
Macroaxis News
few days ago at simplywall.st         
Dont Ignore The Insider Selling In uniQure
Simply Wall St News at Macroaxis
six days ago at thelincolnianonline.com         
uniQure Price Target Lowered to 30.00 at Wells Fargo Company
news
over a week ago at seekingalpha.com         
uniQure GAAP EPS of -4.92 misses by 0.97, revenue of 27.1M misses by 12.3M
seekingalpha News
over a week ago at www.macroaxis.com         
Acquisition by Christian Klemt of 5712 shares of Uniqure NV subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
Acquisition by Jacques Rachelle Suzanne of 8080 shares of Uniqure NV subject to Rule 16b-3
news
over three weeks ago at news.google.com         
uniQure Stock Price Down 6.7 percent - Should You Sell - MarketBeat
Google News at Macroaxis
over three weeks ago at simplywall.st         
Swelling losses havent held back gains for uniQure shareholders since theyre up 147 percent over 1 y...
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
uniQure CSL Behrings Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
Yahoo News
a day ago at gurufocus.com         
FMR LLC Reduces Stake in Sage Therapeutics Inc A Strategic Portfolio Adjustment
Gurufocus Stories at Macroaxis
few days ago at businesswire.com         
Sage Therapeutics Announces RD Leadership Transition
businesswire News
few days ago at finance.yahoo.com         
Sage Geosystems Achieves Awardable Status by the U.S. Department of Defense for the U.S. Air Force G...
Yahoo News
over a week ago at finance.yahoo.com         
Is Sage Therapeutics, Inc. the Best Small-Cap Growth Stock to Buy Now?
Yahoo News
over two weeks ago at thelincolnianonline.com         
Q1 EPS Forecast for Sage Therapeutics Boosted by Analyst
news
over two weeks ago at gurufocus.com         
RTW INVESTMENTS, LP Reduces Stake in Sage Therapeutics Inc
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Sage debuts new conference experience in Atlanta for SMBs Sage Future
Yahoo News
over three weeks ago at aol.com         
Can your EV really power your home Heres how your car battery does more than you think
news
over three weeks ago at gurufocus.com         
Q4 2024 SAGE Therapeutics Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over three weeks ago at benzinga.com         
Biogen Gears Up For Q4 Print Here Are The Recent Forecast Changes From Wall Streets Most Accurate An...
benzinga news
Far too much social signal, news, headlines, and media speculation about Eventide Healthcare that are available to investors today. That information is available publicly through Eventide media outlets and privately through word of mouth or via Eventide internal channels. However, regardless of the origin, that massive amount of Eventide data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Eventide Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Eventide Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Eventide Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Eventide Healthcare alpha.

Other Information on Investing in Eventide Mutual Fund

Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
News Freq…Investor S…